Annals of the Rheumatic Diseases: 80 (11)

Editorial

What is the optimal target for a T2T approach in axial spondyloarthritis? (18 June, 2021)
Joachim Sieper, Denis Poddubnyy

Heroes and pillars of rheumatology

Clemens von Pirquet (6 August, 2021)
Clemens Scheinecker, Dietrich Kraft

Viewpoint

Ultrasound definition of enthesitis in spondyloarthritis and psoriatic arthritis: arrival or starting point? (25 June, 2021)
Emilio Filippucci, Gianluca Smerilli, Andrea Di Matteo, Walter Grassi

Rheumatoid arthritis

Comparison of two dose escalation strategies of methotrexate in active rheumatoid arthritis: a multicentre, parallel group, randomised controlled trial (10 June, 2021)
Siddharth Jain, Varun Dhir, Amita Aggarwal, Ranjan Gupta, Bidyalaxmi Leishangthem, Shankar Naidu, Aastha Khullar, Supriya Maurya, Veena Dhawan, Shefali Khanna Sharma, Aman Sharma, Sanjay Jain
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis (28 May, 2021) Free
Tate M Johnson, Harlan R Sayles, Joshua F Baker, Michael D George, Punyasha Roul, Cheng Zheng, Brian Sauer, Katherine P Liao, Daniel R Anderson, Ted R Mikuls, Bryant R England
Abatacept is second to rituximab at risk of HBsAg reverse seroconversion in patients with rheumatic disease (29 June, 2021)
Ming-Han Chen, I-Cheng Lee, Ming-Huang Chen, Ming-Chih Hou, Chang-Youh Tsai, Yi-Hsiang Huang
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial (29 April, 2021)
Hafsah Nabi, Stylianos Georgiadis, Anne Gitte Loft, Oliver Hendricks, Dorte Vendelbo Jensen, Marlene Andersen, Stavros Chrysidis, Ada Colic, Kamilla Danebod, Mohamad Redha Hussein, Maren Høgberget Kalisz, Salome Kristensen, Niels Lomborg, Natalia Manilo, Heidi Lausten Munk, Jens Kristian Pedersen, Johnny Lillelund Raun, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland, Bente Glintborg

Psoriatic arthritis

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration (3 June, 2021)
Ulf Lindström, Daniela Di Giuseppe, Bénédicte Delcoigne, Bente Glintborg, Burkhard Möller, Adrian Ciurea, Manuel Pombo-Suarez, Carlos Sanchez-Piedra, Kari Eklund, Heikki Relas, Bjorn Gudbjornsson, Thorvardur Jon Love, Gareth T Jones, Catalin Codreanu, Ruxandra Ionescu, Lucie Nekvindova, Jakub Závada, Nuh Atas, Servet Yolbas, Karen Minde Fagerli, Brigitte Michelsen, Žiga Rotar, Matija Tomšič, Florenzo Iannone, Maria Jose Santos, Pedro Avila-Ribeiro, Lykke Midtbøll Ørnbjerg, Mikkel Østergaard, Lennart TH Jacobsson, Johan Askling, Michael J Nissen
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results (23 June, 2021)
Josef S Smolen, Stefan Siebert, Tatiana V Korotaeva, Carlo Selmi, Paul Bergmans, Elisa Gremese, Beatriz Joven-Ibáñez, Gkikas Katsifis, Wim Noël, Michael T Nurmohamed, Pascal Richette, Petros P Sfikakis, Kurt de Vlam, Elke Theander, Laure Gossec
Targeted metabolomic profiling and prediction of cardiovascular events: a prospective study of patients with psoriatic arthritis and psoriasis (28 May, 2021)
Keith Colaco, Ker-Ai Lee, Shadi Akhtari, Raz Winer, Paul Welsh, Naveed Sattar, Iain B McInnes, Vinod Chandran, Paula Harvey, Richard J Cook, Dafna D Gladman, Vincent Piguet, Lihi Eder

Spondyloarthritis

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (6 May, 2021)
Anna Molto, Clementina López-Medina, Filip E Van den Bosch, Annelies Boonen, Casper Webers, Emanuelle Dernis, Floris A van Gaalen, Martin Soubrier, Pascal Claudepierre, Athan Baillet, Mirian Starmans-Kool, Anneke Spoorenberg, Peggy Jacques, Philippe Carron, Rik Joos, Jan Lenaerts, Laure Gossec, Sophie Pouplin, Adeline Ruyssen-Witrand, Laetitia Sparsa, Astrid van Tubergen, Désirée van der Heijde, Maxime Dougados
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter? (15 June, 2021)
Ulf Lindström, Karin Bengtsson, Tor Olofsson, Daniela Di Giuseppe, Bente Glintborg, Helena Forsblad-d'Elia, Lennart T H Jacobsson, Johan Askling

Systemic sclerosis

Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis (24 May, 2021)
Alyxzandria M Gaydosik, Tracy Tabib, Robyn Domsic, Dinesh Khanna, Robert Lafyatis, Patrizia Fuschiotti

Myositis

Familial aggregation and heritability: a nationwide family-based study of idiopathic inflammatory myopathies (15 June, 2021)
Weng Ian Che, Helga Westerlind, Ingrid E Lundberg, Karin Hellgren, Ralf Kuja-Halkola, Marie Holmqvist

Vasculitis

Treatment failure in giant cell arteritis (28 May, 2021)
Sebastian H Unizony, Min Bao, Jian Han, Yves Luder, Andrey Pavlov, John H Stone
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis (2 July, 2021)
Cristina Ponte, Sara Monti, Carlo Alberto Scirè, Paolo Delvino, Nikita Khmelinskii, Alessandra Milanesi, Vítor Teixeira, Fabio Brandolino, Fernando Saraiva, Carlomaurizio Montecucco, João Eurico Fonseca, Wolfgang A Schmidt, Raashid Ahmed Luqmani

Crystal arthropathies

Serum uric acid control for prevention of gout flare in patients with asymptomatic hyperuricaemia: a retrospective cohort study of health insurance claims and medical check-up data in Japan (22 June, 2021)
Ruriko Koto, Akihiro Nakajima, Hideki Horiuchi, Hisashi Yamanaka

Letters

Elderly patients with comorbidities in the definition of difficult-to-treat rheumatoid arthritis (7 May, 2021)
Satoshi Takanashi, Yuko Kaneko, Tsutomu Takeuchi
Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis (3 June, 2021)
Nina Paulshus Sundlisater, Anna-Birgitte Aga, Inge Christoffer Olsen, Hilde Berner Hammer, Till Uhlig, Désirée van der Heijde, Tore K Kvien, Espen A Haavardsholm, Siri Lillegraven
Single cell and spatial transcriptomics in human tendon disease indicate dysregulated immune homeostasis (17 May, 2021)
Moeed Akbar, Lucy MacDonald, Lindsay A N Crowe, Konstantin Carlberg, Mariola Kurowska-Stolarska, Patrik L Ståhl, Sarah J B Snelling, Iain B McInnes, Neal L Millar
Effects of face masks on oxygen saturation and functional measures in patients with connective tissue disorder-associated interstitial lung disease (10 May, 2021)
Anuroopa Vijayan, Sakir Ahmed, Sneha Joseph, Aswathy Sukumaran, Subin Ahmed, Padmanabha Shenoy
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group (26 May, 2021)
Francesco Ursini, Piero Ruscitti, Salvatore D'Angelo, Fabio Cacciapaglia, Rossella De Angelis, Corrado Campochiaro, Francesco Caso, Maria De Santis, Ilenia Di Cola, Simone Parisi, Vincenzo Raimondo, Giuseppina Abignano, Luisa Costa, Jacopo Ciaffi, Lorenzo Dagna, Annamaria Iagnocco, Florenzo Iannone, Riccardo Meliconi, Roberto Giacomelli, Clodoveo Ferri
Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan (21 June, 2021)
Yohei Kirino, Kaoru Takase-Minegishi, Naomi Tsuchida, Lisa Hirahara, Yosuke Kunishita, Ryusuke Yoshimi, Hideaki Nakajima

Electronic pages

Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al
(19 November, 2019) Free
Lea C Berkhout, Merel J l'Ami, Gerrit Jan Wolbink, Theo Rispens
Response to: ‘Comment on ‘Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial’ by Tanaka et al’ by Berkhout et al
(9 December, 2019) Free
Yoshiya Tanaka, Koji Oba, Tsutomu Takeuchi
Gut-derived CD8⁺ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients
(18 October, 2019) Free
Giuliana Guggino, Aroldo Rizzo, Daniele Mauro, Federica Macaluso, Francesco Ciccia
Response to: ‘Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients’ by Guggino et al
(18 December, 2019) Free
Zoya Qaiyum, Eric Gracey, YuChen Yao, Robert D Inman
Gut microbiome in rheumatic diseases (14 November, 2019) Free
Sergey Moiseev, Vilen Rameev, Ekaterina Karovaikina, Lidia Lysenko (Kozlovskaya)
The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus (15 November, 2019) Free
Sheng-Xiao Zhang, Jia Wang, Jun-Wei Chen, Ming-Xing Zhang, Yi-Fan Zhang, Fang-Yuan Hu, Zhi-Qin Lv, Chong Gao, Ya-Feng Li, Xiao-Feng Li
Response to: ‘The level of peripheral regulatory T cells is linked to changes in gut commensal microflora in patients with systemic lupus erythematosus’ by Zhang et al and the phylogeny of a candidate pathobiont in lupus nephritis
(15 November, 2019) Free
Gregg J Silverman, Doua F Azzouz
Bone health in patients with systemic lupus erythematosus (14 October, 2019) Free
Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao
Association between osteoporosis and statins therapy (25 October, 2019) Free
Shih-Wei Lai
Response to: ‘Association between osteoporosis and statins therapy’ by Lai (25 October, 2019) Free
Michael Leutner, Caspar Matzhold, Luise Bellach, Carola Deischinger, Jürgen Harreiter, Stefan Thurner, Peter Klimek, Alexandra Kautzky-Willer
Anti-Ku antibodies: important points to consider (20 November, 2019) Free
Michael Mahler, Minoru Satoh, Marvin J Fritzler
Response to: ‘Anti-Ku antibodies: important points to consider’ by Mahler et al
(20 November, 2019) Free
Mariko Ogawa-Momohara, Yoshinao Muro, Masashi Akiyama
Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers? (5 November, 2019) Free
Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos
Involvement of industry in review articles published in Annals of the Rheumatic Diseases (22 November, 2019) Free
Martin Rudwaleit
Correction: Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase llb, randomised, double blind, placebo-controlled, dose-ranging study
(12 October, 2021)
Correction: Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis
(12 October, 2021)

Main menu

Table of contents

November 2021 - Volume 80 - 11

Editorial

Heroes and pillars of rheumatology

Viewpoint

Rheumatoid arthritis

Psoriatic arthritis

Spondyloarthritis

Systemic sclerosis

Myositis

Vasculitis

Crystal arthropathies

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

November 2021 - Volume 80 - 11

Editorial

Heroes and pillars of rheumatology

Viewpoint

Rheumatoid arthritis

Psoriatic arthritis

Spondyloarthritis

Systemic sclerosis

Myositis

Vasculitis

Crystal arthropathies

Letters

Electronic pages

Issue Information